Stabilization and enhancement of interleukin-2 in vitro bioactivity by new carriers: supramolecular biovectors.
Human recombinant interleukin-2 can be associated and released from supramolecular biovectors (SMBVs), consisting of particles made of polymerized polysaccharides. The particles are substituted with phosphate residues and contain bound lipid molecules (palmitic acid) buried near their surfaces. The association of IL-2 with SMBVs modifies its in vitro bioactivity. SMBVs prolong the growth of IL-2-dependent cells, enhance IL-2 proliferative activity and restore the activity of impaired IL-2. These properties mainly depend on the presence of lipids linked to the SMBV and on both the degree of acylation and the SMBV: IL-2 ratio. SMBVs are therefore good candidates for the stabilization and enhancement of the biological activity of IL-2.
Castignolles
N
N
Lyssavirus Laboratory, Institut Pasteur, Paris, France.
Betbeder
D
D
Ioualalen
K
K
Merten
O
O
Leclerc
C
C
Samain
D
D
Perrin
P
P
D000215:Acylation; D000818:Animals; D002455:Cell Division / Q000276:immunology; D002478:Cells, Cultured; D004337:Drug Carriers; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000494:pharmacology*; D051379:Mice; D011134:Polysaccharides; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000494:pharmacology
D004337:Drug Carriers; D007376:Interleukin-2; D011134:Polysaccharides; D011994:Recombinant Proteins